SCHEMBL32688024

SCHEMBL32688024

CCOC(=O)CC(=O)c1cccc(N2CCN(C(C)=O)CC2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLOD2 O00469 3/20 0.50
PLOD3 O60568 3/20 0.50
PLOD1 Q02809 3/20 0.50
NPC1 O15118 3/20 0.48
PKM P14618 1/20 0.48
ALDH1A1 P00352 5/20 0.47
MAPT P10636 5/20 0.47
MAPK1 P28482 3/20 0.47
LMNA P02545 3/20 0.47
HTT P42858 2/20 0.47
HPGD P15428 1/20 0.47
TSHR P16473 1/20 0.47
CASP1 P29466 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
RAB9A P51151 2/20 0.45
KMT2A Q03164 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
GFER P55789 1/20 0.45
MEN1 O00255 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688239 0.89 PLOD2 (0.53) PLOD2PLOD3PLOD1ALDH1A1MAPT
SCHEMBL32688293 0.88 PLOD2 (0.65) PLOD2PLOD3PLOD1ALDH1A1MAPT
SCHEMBL32688378 0.88 ALDH1A1 (0.55) PLOD2PLOD3PLOD1NPC1PKM
SCHEMBL32688300 0.86 ALDH1A1 (0.54) PLOD2PLOD3PLOD1NPC1ALDH1A1
SCHEMBL32688003 0.85 GPR119 (0.52) PLOD2PLOD3PLOD1ALDH1A1MAPT
SCHEMBL21858310 0.78 KDM4E (0.53) NPC1PKMALDH1A1MAPTMAPK1
SCHEMBL2322269 0.78 MAPT (0.54) NPC1PKMALDH1A1MAPTMAPK1
SCHEMBL13702307 0.78 NPC1 (0.55) NPC1PKMALDH1A1MAPTMAPK1
SCHEMBL32688412 0.76 HSD17B10 (0.69) NPC1PKMALDH1A1MAPTMAPK1
SCHEMBL13702429 0.76 MAPT (0.57) NPC1ALDH1A1MAPTMAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK PLOD2 1971/4885PLOD3 1667/4885PLOD1 1540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.